Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aveo Pharmaceuticals
(NQ:
AVEO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 19, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aveo Pharmaceuticals
< Previous
1
2
3
Next >
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
October 18, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 78.1% to $0.0787 in pre-market trading after gaining 4% on Monday.
Via
Benzinga
US Stock Futures Surge Following Monday's Rally; Goldman Sachs, Johnson & Johnson Earnings In Focus
October 18, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after closing sharply higher in the previous session. The Dow Jones jumped by more than 550 points in the previous...
Via
Benzinga
LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash
October 18, 2022
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
AVEO Pharmaceuticals Return On Capital Employed Insights
August 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 02, 2022
Via
Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
August 30, 2022
U.S. stocks extended losses toward the end of trading, with the Nasdaq Composite dropping around 200 points on Tuesday
Via
Benzinga
Looking Into AVEO Pharmaceuticals's Return On Capital Employed
May 26, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) brought in sales totaling $20.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 40.58%, resulting in a loss of $10.20...
Via
Benzinga
Recap: AVEO Pharmaceuticals Q1 Earnings
May 05, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Preview: AVEO Pharmaceuticals
May 04, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that AVEO...
Via
Benzinga
AVEO Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 18, 2022
Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion....
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
March 15, 2022
Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...
Via
Benzinga
68 Biggest Movers From Yesterday
March 16, 2022
Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...
Via
Benzinga
AVEO Pharmaceuticals's Return On Capital Employed Insights
March 15, 2022
According to Benzinga Pro data, during Q4, AVEO Pharmaceuticals (NASDAQ:AVEO) posted sales of $17.65 million. Earnings were up 30.03%, but AVEO Pharmaceuticals still reported an...
Via
Benzinga
96 Biggest Movers From Yesterday
March 15, 2022
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex...
Via
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
March 14, 2022
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,...
Via
Benzinga
Recap: AVEO Pharmaceuticals Q4 Earnings
March 14, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q4 earnings results on Monday, March 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Preview For AVEO Pharmaceuticals
March 11, 2022
AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Earnings Scheduled For March 14, 2022
March 14, 2022
Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...
Via
Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
February 15, 2022
Aveo Pharmaceuticals Inc (NASDAQ: AVEO) will present new long-term progression-free survival (PFS) data from the Phase 3 TIVO-3 study in kidney cancer at the 2022...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...
Via
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA® (tivozanib) for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
January 05, 2022
From
NiKang Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
AVEO Oncology Announces Appointment of Jeb Ledell as Chief Operating Officer
December 01, 2021
From
AVEO Oncology
Via
Business Wire
AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences
November 10, 2021
From
AVEO Oncology
Via
Business Wire
AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
November 08, 2021
From
AVEO Oncology
Via
Business Wire
AVEO Oncology to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
November 01, 2021
From
AVEO Oncology
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.